The Autotransporter Story Ian R

The Autotransporter Story Ian R

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, Dec. 2004, p. 692–744 Vol. 68, No. 4 1092-2172/04/$08.00ϩ0 DOI: 10.1128/MMBR.68.4.692–744.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. Type V Protein Secretion Pathway: the Autotransporter Story Ian R. Henderson,1* Fernando Navarro-Garcia,2 Mickae¨l Desvaux,1 Rachel C. Fernandez,3 and Dlawer Ala’Aldeen4 Division of Immunity and Infection, University of Birmingham, Birmingham,1 and Division of Microbiology & Infectious Diseases, University Hospital, Nottingham,4 United Kingom; Department of Cell Biology, CINVESTAV, Mexico City, Mexico2; and Department of Microbiology & Immunology, University of British Columbia, Vancouver, British Columbia, Canada3 INTRODUCTION .......................................................................................................................................................693 Downloaded from SECRETION BY NUMBERS: PROTEIN SECRETION MECHANISMS IN GRAM-NEGATIVE BACTERIA...........................................................................................................................................................693 Type I Protein Secretion........................................................................................................................................694 Two-Step Type II Protein Secretion .....................................................................................................................695 The Injectisome: Type III Protein Secretion.......................................................................................................696 Type IV Protein and Nucleoprotein Secretion....................................................................................................697 TYPE V PROTEIN SECRETION.............................................................................................................................697 Autotransporter Secretion Pathway (Type Va)...................................................................................................698 Inner membrane transport................................................................................................................................699 Periplasmic transit .............................................................................................................................................701 http://mmbr.asm.org/ ␤-Domain .............................................................................................................................................................702 Translocation of the passenger domain...........................................................................................................702 Processing of autotransporters at the surface................................................................................................704 Energy of transport ............................................................................................................................................705 Evolution and distribution of autotransporter proteins ...............................................................................705 Two-Partner Secretion Pathway (Type Vb).........................................................................................................705 Type Vc.....................................................................................................................................................................708 CLUSTER 1: SUBTILASE FAMILY OF AUTOTRANSPORTERS ....................................................................709 Ssp.............................................................................................................................................................................709 PspA and PspB........................................................................................................................................................709 Ssa1...........................................................................................................................................................................709 on December 9, 2018 by guest SphB1 .......................................................................................................................................................................709 AspA/NalP................................................................................................................................................................710 CLUSTERS 2 AND 11: HELICOBACTER PYLORI AUTOTRANSPORTERS...................................................710 VacA, the Vacuolating Cytotoxin ..........................................................................................................................710 Molecular and structural features ...................................................................................................................710 Vacuolating activity ............................................................................................................................................711 Other functions ...................................................................................................................................................711 Epidemiology of H. pylori infection ..................................................................................................................711 BabA, SabA, and AlpA ...........................................................................................................................................712 CLUSTERS 3 AND 4: AIDA AUTOTRANSPORTER FAMILY...........................................................................713 AIDA-I ..........................................................................................................................................................................713 Antigen 43 ................................................................................................................................................................714 IcsA ...........................................................................................................................................................................716 TibA, ShdA, and MisL ...........................................................................................................................................716 AutA and AutB ........................................................................................................................................................718 CLUSTERS 5 AND 8: SERINE PROTEASE AUTOTRANSPORTERS .............................................................718 IgA1 Proteases.........................................................................................................................................................718 H. influenzae Adhesion and Penetration Protein (Hap) ....................................................................................720 N. meningitidis App and MspA Autotransporter Proteins.................................................................................720 Serine Protease Autotransporters of the Enterobacteriaceae.............................................................................721 Tsh ........................................................................................................................................................................721 SepA......................................................................................................................................................................722 EspC .....................................................................................................................................................................722 EspP......................................................................................................................................................................722 Pet .........................................................................................................................................................................723 * Corresponding author. Mailing address: Division of Immunity and Infection, The Medical School, University of Birmingham, Birming- ham B15 2TT, United Kingdom. Phone: 44 121 414 4368. Fax: 44 121 414 3599. E-mail: [email protected]. 692 VOL. 68, 2004 TYPE V SECRETION 693 Pic .........................................................................................................................................................................723 SigA.......................................................................................................................................................................725 Sat .........................................................................................................................................................................725 Vat.........................................................................................................................................................................725 Others...................................................................................................................................................................725 CLUSTER 6: BORDETELLA AUTOTRANSPORTERS ........................................................................................726 Identification of Autotransporters in the Bordetella Genomes .........................................................................726 Pertactin...................................................................................................................................................................727

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    53 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us